GEN vs. NTES, SNOW, PLTR, ADSK, TEAM, DDOG, SQ, EA, VEEV, and HUBS
Should you be buying Genesis Healthcare stock or one of its competitors? The main competitors of Genesis Healthcare include NetEase (NTES), Snowflake (SNOW), Palantir Technologies (PLTR), Autodesk (ADSK), Atlassian (TEAM), Datadog (DDOG), Block (SQ), Electronic Arts (EA), Veeva Systems (VEEV), and HubSpot (HUBS). These companies are all part of the "prepackaged software" industry.
NetEase (NASDAQ:NTES) and Genesis Healthcare (NYSE:GEN) are both large-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and risk.
NetEase has a net margin of 28.75% compared to NetEase's net margin of 17.83%. NetEase's return on equity of 155.48% beat Genesis Healthcare's return on equity.
NetEase pays an annual dividend of $4.31 per share and has a dividend yield of 4.7%. Genesis Healthcare pays an annual dividend of $0.50 per share and has a dividend yield of 2.0%. NetEase pays out 66.8% of its earnings in the form of a dividend. Genesis Healthcare pays out 55.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. NetEase has increased its dividend for 1 consecutive years. NetEase is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
NetEase has higher revenue and earnings than Genesis Healthcare. NetEase is trading at a lower price-to-earnings ratio than Genesis Healthcare, indicating that it is currently the more affordable of the two stocks.
NetEase has a beta of 0.58, suggesting that its stock price is 42% less volatile than the S&P 500. Comparatively, Genesis Healthcare has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500.
11.1% of NetEase shares are held by institutional investors. Comparatively, 82.1% of Genesis Healthcare shares are held by institutional investors. 54.7% of NetEase shares are held by insiders. Comparatively, 3.3% of Genesis Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
NetEase received 197 more outperform votes than Genesis Healthcare when rated by MarketBeat users. Likewise, 69.02% of users gave NetEase an outperform vote while only 65.78% of users gave Genesis Healthcare an outperform vote.
NetEase currently has a consensus target price of $125.71, indicating a potential upside of 37.86%. Genesis Healthcare has a consensus target price of $26.40, indicating a potential upside of 6.41%. Given Genesis Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe NetEase is more favorable than Genesis Healthcare.
In the previous week, NetEase had 37 more articles in the media than Genesis Healthcare. MarketBeat recorded 40 mentions for NetEase and 3 mentions for Genesis Healthcare. Genesis Healthcare's average media sentiment score of 0.52 beat NetEase's score of 0.00 indicating that NetEase is being referred to more favorably in the media.
Summary
NetEase beats Genesis Healthcare on 15 of the 21 factors compared between the two stocks.
Get Genesis Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Genesis Healthcare Competitors List
Related Companies and Tools
